ACM
CNMD icon

Aster Capital Management’s CONMED CNMD Stock Holding History

Aster Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5K Sell
571
-152
-21% -$6.18K 0.01% 491
2025
Q4 		$29.4K Buy
723
+581
+409% +$25.3K 0.01% 550
2025
Q3 		$6.68K Sell
142
-788
-85% -$40.9K ﹤0.01% 786
2025
Q2 		$48.4K Sell
930
-25
-3% -$1.37K 0.01% 609
2025
Q1 		$56.5K Buy
955
+901
+1,669% +$58.1K 0.01% 789
2024
Q4 		$3.7K Buy
+54
New +$3.76K ﹤0.01% 899

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Aster Capital Management's CNMD Position: Q1 2026 in Review

Aster Capital Management reduced its CONMED (CNMD) stake by 21% in Q1 2026, selling an estimated $6.18K and leaving 571 shares worth $34.5K. The position accounts for 0.01% of the portfolio, ranked #491.

Aster Capital Management first reported a position in CNMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $56.5K in Q1 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Aster Capital Management held 571 shares of CONMED worth $34.5K as of Q1 2026.
  • Aster Capital Management sold 152 CONMED shares in Q1 2026, an estimated $6.18K.
  • CONMED made up 0.01% of Aster Capital Management's portfolio in Q1 2026, its #491 holding.
  • Aster Capital Management first reported a position in CONMED in Q4 2024 and has held it in 6 quarters since.
  • Aster Capital Management's CONMED position peaked at $56.5K in Q1 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.